90.15
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Ventas Inc stock is traded at $90.15, with a volume of 718.24K.
It is up +1.37% in the last 24 hours and down -1.99% over the past month.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
See More
Previous Close:
$89.01
Open:
$89.49
24h Volume:
718.24K
Relative Volume:
0.19
Market Cap:
$46.24B
Revenue:
$6.13B
Net Income/Loss:
$272.21M
P/E Ratio:
163.28
EPS:
0.5521
Net Cash Flow:
$1.38B
1W Performance:
-2.20%
1M Performance:
-1.99%
6M Performance:
+5.85%
1Y Performance:
+32.67%
Ventas Inc Stock (VTR) Company Profile
Name
Ventas Inc
Sector
Industry
Phone
(312) 660-3800
Address
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, DOC, OHI, AHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
VTR
Ventas Inc
|
90.14 | 45.66B | 6.13B | 272.21M | 1.38B | 0.5521 |
|
WELL
Welltower Inc
|
234.62 | 165.93B | 11.75B | 1.46B | 2.19B | -0.6014 |
|
DOC
Healthpeak Properties Inc
|
20.77 | 14.25B | 2.87B | 250.10M | 1.13B | 0.3188 |
|
OHI
Omega Healthcare Investors Inc
|
46.20 | 13.90B | 1.24B | 655.98M | 857.80M | 2.063 |
|
AHR
American Healthcare Reit Inc
|
53.66 | 10.14B | 2.37B | 101.67M | 169.19M | 0.5775 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | Goldman | Buy |
| Oct-01-25 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-19-25 | Initiated | UBS | Neutral |
| Jun-23-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-07-25 | Upgrade | Argus | Hold → Buy |
| Jan-17-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-01-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-26-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-30-24 | Initiated | Deutsche Bank | Buy |
| Jan-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-07-23 | Upgrade | Wedbush | Neutral → Outperform |
| Oct-11-23 | Initiated | Exane BNP Paribas | Outperform |
| Oct-03-23 | Initiated | Wedbush | Neutral |
| Sep-20-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-11-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-23-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-20-23 | Initiated | Wells Fargo | Overweight |
| Nov-01-22 | Reiterated | Credit Suisse | Outperform |
| Nov-01-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-10-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-30-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-23-22 | Initiated | Credit Suisse | Outperform |
| Jun-03-22 | Initiated | CapitalOne | Overweight |
| May-18-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-11-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Mar-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-01-22 | Initiated | Credit Suisse | Neutral |
| Jan-20-22 | Upgrade | Mizuho | Neutral → Buy |
| Dec-14-21 | Upgrade | Citigroup | Neutral → Buy |
| Nov-22-21 | Downgrade | SMBC Nikko | Outperform → Neutral |
| Oct-04-21 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-23-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-07-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-26-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Jul-14-21 | Resumed | Mizuho | Neutral |
| Jun-15-21 | Initiated | Wolfe Research | Outperform |
| Jun-11-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-13-21 | Upgrade | KeyBanc Capital Markets | Underweight → Overweight |
| May-13-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-08-21 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jan-06-21 | Initiated | Robert W. Baird | Neutral |
| Nov-30-20 | Upgrade | BofA Securities | Underperform → Buy |
| Nov-10-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Argus | Buy → Hold |
| Sep-02-20 | Resumed | Stifel | Hold |
| Aug-20-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-14-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-14-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-15-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Mar-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Mar-23-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Mar-10-20 | Downgrade | Jefferies | Buy → Underperform |
| Feb-28-20 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Jan-22-20 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Jan-17-20 | Upgrade | Jefferies | Hold → Buy |
| Dec-20-19 | Resumed | Mizuho | Neutral |
| Dec-10-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Nov-19-19 | Upgrade | Argus | Hold → Buy |
| Oct-30-19 | Downgrade | Stifel | Buy → Hold |
| Oct-28-19 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Oct-28-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Ventas Inc Stock (VTR) Latest News
Ventas, Inc. $VTR Stock Position Raised by Handelsbanken Fonder AB - MarketBeat
Jefferies Adjusts Price Target on Ventas to $102 From $109, Maintains Buy Rating - marketscreener.com
Ventas, Inc. (VTR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Ventas Inc (VTR) Shares Fall 5.4% -- What GF Score of 80 Tells I - GuruFocus
Ventas Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Why Is S&P 500 Ventas (NYSE:VTR) Raising Its 2026 FFO Outlook? - Kalkine Media
Ventas Slides 3.8% as Investors Appear to Take Profits After Strong Run - quiverquant.com
BMO Capital Adjusts Price Target on Ventas to $107 From $105, Keeps Outperform Rating - marketscreener.com
Ventas Inc. stock underperforms Monday when compared to competitors - MarketWatch
Penn Series Real Estate Securities Fund's Ventas Inc(VTR) Holding History - GuruFocus
Raised 2026 Earnings Outlook On Senior Housing Strength Might Change The Case For Investing In Ventas (VTR) - simplywall.st
Are Wall Street Analysts Bullish on Ventas Stock? - inkl
Ventas (VTR) Q2 2026 Earnings Call Transcript - AOL.com
Ventas, Inc. (VTR) Stock Forecasts - Yahoo! Finance Canada
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventas Inc (VEN) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
Pacer Advisors Inc. Has $2.83 Million Stock Holdings in Ventas, Inc. $VTR - MarketBeat
CEO Debra Cafaro Leads The Way at Health Care REIT Ventas - Nareit
Ventas Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Ventas (NYSE:VTR) Issues FY 2026 Earnings Guidance - MarketBeat
Bank of America Corp DE Has $208.47 Million Stock Position in Ventas, Inc. $VTR - MarketBeat
Ventas, Inc. (VTR) Stock forecasts - Yahoo Finance Singapore
Ventas (NYSE: VTR) grants 10,694 and 4,314 RSUs to EVP Wattula - Stock Titan
Ventas (NYSE: VTR) insider report lists executive Andy Wattula - Stock Titan
Does Ventas (VTR) Raising 2026 Earnings Guidance Reframe Its Senior Housing Investment Story? - webull.com
VENTAS INC : BMO RAISES TARGET PRICE TO $105 FROM $100 - Moomoo
BofA Securities Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $113 - Moomoo
Royal Bank of Canada Has $44.24 Million Stock Position in Ventas, Inc. $VTR - MarketBeat
Quantinno Capital Management LP Has $15.75 Million Stock Position in Ventas, Inc. $VTR - MarketBeat
Ventas’ Q2 Earnings Beat on Every Line. Is the Stock Already Priced For It? - TIKR.com
Ventas Inc. Earnings Call Signals Senior Housing Strength - The Globe and Mail
Ventas Q2 Earnings Call Highlights - MarketBeat
JPMORGAN CHASE & CO Buys Ventas Inc (VTR) -- Shares Look 32% Ove - GuruFocus
Cantor Fitzgerald Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $102 - Moomoo
Ventas, Inc. Common StockAlan Armstrong Congressional Trade on Mar. 27, 2026 - Quiver Quantitative
Ventas (VTR) Senior Housing Momentum Fuels Stronger FFO Growth - Sahm
Ventas, Inc. Stock 12‑Month Price Target Raised to $99.67, Implies 2% Upside - TradingView
Ventas Q2 2026 slides: SHOP drives 16% NOI growth, shares fall on valuation - Investing.com
Ventas reports Q2 2026: Normalized FFO $0.97/share, Same-Store Cash NOI +10% - TradingView
Ventas faces earnings test as senior housing momentum meets transition - Investing.com
First Trust Advisors LP Buys 116,978 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas Inc expected to post earnings of 13 cents a shareEarnings Preview - TradingView
JPMorgan Chase & Co. (VTR) discloses 42.6M Ventas shares in 13G/A filing - Stock Titan
Ventas (NYSE:VTR) Sets New 52-Week HighHere's Why - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Purchases 333,273 Shares of Ventas, Inc. $VTR - MarketBeat
Renaissance Technologies LLC Cuts Stock Holdings in Ventas, Inc. $VTR - MarketBeat
BROOKFIELD Corp ON Sells 106,208 Shares of Ventas, Inc. $VTR - MarketBeat
Bank of Nova Scotia Cuts Stock Position in Ventas, Inc. $VTR - MarketBeat
Did Strong Q2 Senior Housing Gains Amid Headwinds Just Shift Ventas' (VTR) Investment Narrative? - simplywall.st
Sei Investments Co. Buys 21,378 Shares of Ventas, Inc. $VTR - MarketBeat
NewEdge Wealth LLC Acquires 14,963 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas Inc Stock (VTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):